AKTX

AKTX

Akari Therapeutics plc ADS

$1.171+0.000 (0.017%)

Echtzeitkurs

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.171

Hoch

$1.171

Tief

$1.171

Volumen

0.04M

Unternehmensfundamentaldaten

Handelsstatistiken

Ähnliche Nachrichten

GlobeNewswire

Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Advancing development of novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads to treat multiple cancer tumors Rounding out executive team with deep oncology experience by appointing new Head of Business

Mehr anzeigen
Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire

Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody

Mehr anzeigen
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology